OXYTOCIN — Class II drug recall D-0106-2027
Ongoing recall by Eagle Pharma Outsourcing LLC, reported 2026-11-04, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0106-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eagle Pharma Outsourcing LLC, Hoover, AL, United States |
| Recall initiated | 2026-10-08 |
| Classified | 2026-10-28 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| NDC | 69852-0030-50 |
| Lot numbers | OXY30-1006 |
| Expiration dates | 2026-10-10 |
Product
OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0106-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.